Resources
Filter by Topic
- Press Releases
NorstellaLinQ dataset achieves highest scores on data quality for claims backbone real-world data (RWD) use cases and is now available to Atropos Evidence Network members
- Publication
By Sumit Verma, Mike Blecker, Thomas Edwards, Meg Richards, Shreekant V. Parasuraman, Evan M. Braunstein, Pankit Vachhani
- Case Study
Fill out the form below to download the case study.
- Booklets
Volume 5: A Collection of Recent Regulatory Decisions Based on RWE
- Press Releases
NorstellaLinQ integrates 74 billion connected data points, paving the way for breakthroughs in drug development and commercialization
- Blogs
A Q&A with Panalgo’s General Manager, Kevin D’Ambrosia
- eBook
Preeclampsia is a life-threatening form of hypertension that occurs during pregnancy – and the cases are on the rise in the US.
Faster Evidence, Fewer Bottlenecks: How IHD Is Redefining What’s Possible in Evidence Generation
As the demands on real-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the tools supporting that work need to evolve just as quickly.
Accelerating HEOR and Real-World Evidence: How IHD Helps Researchers Turn Evidence Into Impact
Health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE) teams are under growing pressure to deliver meaningful insights faster than ever before. As healthcare stakeholders demand stronger evidence of clinical, economic, and humanistic value across the product life cycle, researchers need more than data—they need the right combination of technology, expertise, and fit-for-purpose evidence sources to turn research into impact.
How Pharma Leaders Are Rethinking Evidence Generation in the AI Era
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
Where Treatment Slows in Metastatic NSCLC: A Real-World Data Analysis of Care Delays and Access Barriers
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Pharma’s New Regulatory Reality: Building Evidence for Launch and Beyond
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Smarter Data, Better Outcomes: How Real-World Data Is Transforming Evidence Generation Across the Product Lifecycle
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization